CareFusion outlines 2012 financial targets following second quarter

CareFusion has outlined its financial targets for the 2012 full-year period, following a second quarter in which it made progress towards its long-term goals.

Preliminary data from the organisation shows that revenue is expected to fall between $910 and $915 million (594.86 to 598.07 million pounds), while income is forecast as being between $141 and $146 million.

According to chairman and chief executive officer Kieran Gallahue, the company's medical systems segment anchored the business, while core procedural products grew faster than the market.

CareFusion expects full-year consolidated revenue for fiscal 2012 to grow between three to five percent on a constant currency basis compared to 2011, when the company generated a total of $3.53 billion.

Mr Gallahue said: "During the quarter, we continued to make good progress with our simplification initiatives and remain committed to our long-term goals."

Last month, the company outlined a number of new product innovations at the American Society for Health-System Pharmacists conference, including additions to the Pyxis and Rowa ranges.